September 3, 2009 The U.S. Food and Drug Administration approved Intuniv, an extended release formulation of guanfacin as a pediatric treatment for attention deficit/hyperactivity disorder (ADHD). Clinical trials found the medication was better than a placebo at relieving ADHD symptoms for 24 hours. The medication, in dosage strengths of 1 mg, 2 mg, 3 mg, and 4 mg, will be available as of November 2009. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

FDA NDA Approval Letter to Shire PLC for ADHD Medication Intuniv

September 3, 2009 The U.S. Food and Drug Administration approved Intuniv, an extended release formulation of guanfacin as a pediatric treatment for attention deficit/hyperactivity disorder (ADHD). Clinical trials found the medication was better than a placebo at relieving ADHD symptoms for 24 hours. The medication, in dosage strengths of 1 mg, 2 mg, 3 mg, and 4 mg, will be available as of November 2009. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.